Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Quarterly Report · 10-Q

RWB Health Inc.

Quarterly Report

Filed Aug 4, 2026Accepted Aug 4, 2026, 5:27 PM EDTCIK 2107166Accession 0001477932-26-004712
Share

Company context

We are a newly organized company to sell a line of CBD products into the North America marketplace. Initially the Company has obtained an exclusive licence to sell the products of Natures Life CBD r.s.o (“Natures Life”) in North America including Canada, Mexico and the United States, and have non-exclusive rights to sell their products globally. Since 2018 Natures Life has been one of Europe’s established CBD brands and is recognized by the United Kingdoms’ Regulated Food Authority as a registered novel food.

Recent company filings

  1. NT 10-Q filingMay 15, 2026
  2. EFFECT filingMay 8, 2026
  3. S-1/A filingApr 23, 2026
  4. S-1/A filingApr 13, 2026
  5. S-1/A filingMar 26, 2026

As-filed source

Primary evidence